Bluejay Diagnostics: Mark Feinberg

Bluejay Diagnostics has appointed Mark Feinberg the company's chief medical advisor to direct its clinical development programs and provide strategic medical and scientific leadership. Feinberg is an associate professor of medicine at Harvard Medical School and an affiliated faculty member at the Harvard Stem Cell Institute. He is also director of cardiovascular RNA biology research at Brigham and Women's Hospital.